RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Christian BegerTheresa KargJan B HinrichsBastian RingeHermann HallerBernhard C MeyerSusanne V FleigPublished in: Blood pressure (2023)
In patients with resistant hypertension, low renin in the presence of RASi is a strong indicator for autonomous aldosterone secretion. It may serve as an on-medication screening test for PA to select for formal PA work up.